|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-10-16
|
|
pubmed:abstractText |
Before this study was conducted, the clinical and therapeutic significance of immunohistochemical evaluation of thymidylate synthase (TS) in patients with gastric carcinoma had not yet been clarified.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1300-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9762929-Adenocarcinoma,
pubmed-meshheading:9762929-Adult,
pubmed-meshheading:9762929-Aged,
pubmed-meshheading:9762929-Aged, 80 and over,
pubmed-meshheading:9762929-Antibodies,
pubmed-meshheading:9762929-Antimetabolites, Antineoplastic,
pubmed-meshheading:9762929-Carcinoma, Signet Ring Cell,
pubmed-meshheading:9762929-Drug Resistance,
pubmed-meshheading:9762929-Female,
pubmed-meshheading:9762929-Fluorouracil,
pubmed-meshheading:9762929-Humans,
pubmed-meshheading:9762929-Immunohistochemistry,
pubmed-meshheading:9762929-Male,
pubmed-meshheading:9762929-Middle Aged,
pubmed-meshheading:9762929-Multivariate Analysis,
pubmed-meshheading:9762929-Neoplasm Invasiveness,
pubmed-meshheading:9762929-Neoplasm Metastasis,
pubmed-meshheading:9762929-Prognosis,
pubmed-meshheading:9762929-Stomach Neoplasms,
pubmed-meshheading:9762929-Survival Rate,
pubmed-meshheading:9762929-Thymidylate Synthase
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.
|
|
pubmed:affiliation |
First Department of Surgery, Kobe University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article
|
